Interview by Ella Hermer, March 2025 Dr. Namasivayam-MacDonald is a clinically trained speech pathologist and an Assistant Professor in...

by Zaid Firas , March 2025 As Alzheimer’s disease (AD) continues to affect millions worldwide, scientists are uncovering a powerful new...

Figure 1: Dr. Krista Lanctôt in 2022 after being appointed to the inaugural Bernick Chair in Geriatric Psychopharmacology for her...

The human gut microbiota, comprised of trillions of microorganisms existing symbiotically within the gastrointestinal tract, plays a...

The article "The Role of Microglia in the Spread of Tau: Relevance for Tauopathies" by Juan R. Perea et al. provides significant insights...

This study by Mervat et al. aimed to evaluate the potential of aqueous extracts from Rosemary (Rosmarinus officinalis L.) and Saffron...

Alzheimer’s disease (AD) is considered to be one of the most common degenerative diseases, largely affecting the elderly population. This...

Alzheimer’s disease (AD) is the most prominent form of dementia caused by aging (Choi et al., 2018). This disease negatively impacts the...

An article published in Nature Aging in September 2023 by a research group (Lau et al.) from Hong Kong identified a potential new target...

This article by Sperling et al. looked at a potential treatment, solanezumab, for Alzheimer's disease. Solanezumab, a monoclonal...